ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements
ZIM Laboratories Limited allotted 48,726 equity shares to a subsidiary employee under its ESOS 2023 scheme. The allotment, valued at ₹0.38 Crore, increases the company's paid-up capital to ₹53.55 Crore. The new shares rank pari-passu with existing equity.
ZIM Laboratories Limited has invested Rs. 0.89 Crore (AUD 1,35,000) into its subsidiary ZIMTAS Pty Ltd. This investment is part of a total approved amount of up to Rs. 2 Crore for equity shares in the subsidiary.
Zim Laboratories Limited invested ₹0.89 Crore (AUD 1,35,000) into the equity shares of its subsidiary, ZIMTAS Pty Ltd. Following this investment, the company now holds 99.96% of the subsidiary's total share capital. This move follows an approved investment limit of up to ₹2.00 Crore.